ReadR

ReadR

ReadR: Read and Share all content, headlines, news and trends results with Seefinish ReadR App.


Discover Content : Trends

Discover real-time trending topics, news headlines, twitter trends, google trends, hashtags, and content from different countries in the world.

Search Here

Navigation Tabs

Top Countries

Select Country:๐ŸŒ

Worldwide ๐ŸŒ | Nigeria ๐Ÿ‡ณ๐Ÿ‡ฌ | South Africa ๐Ÿ‡ฟ๐Ÿ‡ฆ | Kenya ๐Ÿ‡ฐ๐Ÿ‡ช |Brazil ๐Ÿ‡ง๐Ÿ‡ท| Canada ๐Ÿ‡จ๐Ÿ‡ฆ | United Kingdom ๐Ÿ‡ฌ๐Ÿ‡ง| United States ๐Ÿ‡บ๐Ÿ‡ธ



Headline : BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping

Read more from the original article on here at www.prnewswire.com.





Tags : #billiontoone #announces #green #journal #publication #underscores #role #cellfree #dna #nipt #fetal #red #blood #cell #antigen #genotyping



No. of Paragraph 16

ACOG supports cfDNA testing as a reasonable alternative for fetal RBC testing among alloimmunized patients

MENLO PARK, Calif., July 26, 2024 /PRNewswire/ -- BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, is thrilled to announce a new publication that shows cfDNA analysis is highly sensitive and specific for determining fetal antigen genotype as early as 10 weeks gestation. The new study published online in Obstetrics and Gynecology, the official journal of the American College of Obstetricians and Gynecologists (ACOG), also known as "The Green Journal," supports the implementation of cfDNA testing to manage alloimmunized pregnancies in the United States. This study follows the recent ACOG clinical practice update that supports cfDNA testing as a reasonable alternative to amniocentesis for fetal RBC testing among alloimmunized patients.

Hemolytic disease of the fetus or newborn (HDFN) is a potentially life-threatening form of anemia caused by alloimmunization. ACOG recommends testing the reproductive partner's antigen status when alloimmunization is diagnosed in pregnancy.ย However, rates of reproductive partner screening uptake are low, and results can be misleading in the setting of nonpaternity.

In September 2022, BillionToOne's UNITY Fetal Antigen NIPT became the first commercially available cfDNA test in the US, providing highly accurate assessments of the fetal status for RhD, c, C, E, K and Fya antigens. It is the only clinically available NIPT in the US that includes antigens beyond RhD and is offered as an add on to UNITY Complete, the first and only test that uses cell-free DNA to provide precise fetal insights for both recessive and chromosomal conditions.

Read more from the original article on here at www.prnewswire.com.


Related Headlines : BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.